Literature DB >> 23759278

Severity classification on the Hamilton Depression Rating Scale.

Mark Zimmerman1, Jennifer H Martinez, Diane Young, Iwona Chelminski, Kristy Dalrymple.   

Abstract

BACKGROUND: Symptom severity as a moderator of treatment response has been the subject of debate over the past 20 years. Each of the meta- and mega-analyses examining the treatment significance of depression severity used the Hamilton Depression Rating Scale (HAMD), wholly, or in part, to define severity, though the cutoff used to define severe depression varied. There is limited empirical research establishing cutoff scores for bands of severity on the HAMD. The goal of the study is to empirically establish cutoff scores on the HAMD in their allocation of patients to severity groups.
METHODS: Six hundred twenty-seven outpatients with current major depressive disorder were evaluated with a semi-structured diagnostic interview. Scores on the 17-item HAMD were derived from ratings according to the conversion method described by Endicott et al. (1981). The patients were also rated on the Clinical Global Index of Severity (CGI). Receiver operating curves were computed to identify the cutoff that optimally discriminated between patients with mild vs. moderate and moderate vs. severe depression.
RESULTS: HAMD scores were significantly lower in patients with mild depression than patients with moderate depression, and patients with moderate depression scored significantly lower than patients with severe depression. The cutoff score on the HAMD that maximized the sum of sensitivity and specificity was 17 for the comparison of mild vs. moderate depression and 24 for the comparison of moderate vs. severe depression. LIMITATIONS: The present study was conducted in a single outpatient practice in which the majority of patients were white, female, and had health insurance. Although the study was limited to a single site, a strength of the recruitment procedure was that the sample was not selected for participation in a treatment study, and exclusion and inclusion criteria did not reduce the representativeness of the patient groups. The analyses were based on HAMD scores extracted from ratings on the SADS. However, we used Endicott et al.'s (1981) empirically established formula for deriving a HAMD score from SADS ratings, and our results concurred with other small studies of the mean and median HAMD scores in severity groups.
CONCLUSIONS: Based on this large study of psychiatric outpatients with major depressive disorder we recommend the following severity ranges for the HAMD: no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe depression (≥24).
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depression; Hamilton depression rating scale; Severity

Mesh:

Year:  2013        PMID: 23759278     DOI: 10.1016/j.jad.2013.04.028

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  254 in total

1.  Psychometric properties of the Hamilton Depression Rating Scale in multiple sclerosis.

Authors:  Simona Raimo; Luigi Trojano; Daniele Spitaleri; Vittorio Petretta; Dario Grossi; Gabriella Santangelo
Journal:  Qual Life Res       Date:  2015-02-11       Impact factor: 4.147

2.  Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's disease.

Authors:  F Imperiale; F Agosta; E Canu; V Markovic; A Inuggi; M Jecmenica-Lukic; A Tomic; M Copetti; S Basaia; V S Kostic; M Filippi
Journal:  Mol Psychiatry       Date:  2017-03-07       Impact factor: 15.992

3.  Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens
Journal:  J Pediatr Psychol       Date:  2018-10-01

4.  Developmental evaluation of family functioning deficits in youths and young adults with childhood-onset bipolar disorder.

Authors:  Heather A MacPherson; Amanda L Ruggieri; Rachel E Christensen; Elana Schettini; Kerri L Kim; Sarah A Thomas; Daniel P Dickstein
Journal:  J Affect Disord       Date:  2018-04-16       Impact factor: 4.839

5.  The Relations of Cognitive, Behavioral, and Physical Activity Variables to Depression Severity in Traumatic Brain Injury: Reanalysis of Data From a Randomized Controlled Trial.

Authors:  Charles H Bombardier; Jesse R Fann; Evette J Ludman; Steven D Vannoy; Joshua R Dyer; Jason K Barber; Nancy R Temkin
Journal:  J Head Trauma Rehabil       Date:  2017 Sep/Oct       Impact factor: 2.710

6.  Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up.

Authors:  Michael H Antoni; Jamie M Jacobs; Laura C Bouchard; Suzanne C Lechner; Devika R Jutagir; Lisa M Gudenkauf; Bonnie B Blomberg; Stefan Glück; Charles S Carver
Journal:  Gen Hosp Psychiatry       Date:  2016-10-22       Impact factor: 3.238

7.  Insomnia in alcohol dependent subjects is associated with greater psychosocial problem severity.

Authors:  Ninad S Chaudhary; Kyle M Kampman; Henry R Kranzler; Michael A Grandner; Swarnalata Debbarma; Subhajit Chakravorty
Journal:  Addict Behav       Date:  2015-06-20       Impact factor: 3.913

8.  PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.

Authors:  Malek Bajbouj; Sabine Aust; Jan Spies; Ana-Lucia Herrera-Melendez; Sarah V Mayer; Maike Peters; Christian Plewnia; Andreas J Fallgatter; Lukas Frase; Claus Normann; Nora Behler; Linda Wulf; Eva-Lotta Brakemeier; Frank Padberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-12-06       Impact factor: 5.270

Review 9.  Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-04-11

10.  Differential engagement of cognitive control regions and subgenual cingulate based upon presence or absence of comorbid anxiety with depression.

Authors:  Lisanne M Jenkins; Jonathan P Stange; Katie L Bessette; Yi-Shin Chang; Samantha D Corwin; Kristy A Skerrett; Víctor G Patrón; Jon-Kar Zubieta; Natania A Crane; Alessandra M Passarotti; Daniel S Pine; Scott A Langenecker
Journal:  J Affect Disord       Date:  2018-08-01       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.